Dr. Rudi Moerck, CEO of Valensa International will address the importance of reducing chronic inflammation in the muscles and joints. He will discuss the properties of a clinically proven, patented (non glucosamine) formulation developed by Valensa for its Flex Pro line. Flex Pro MD® is over three times more effective than Glucosamine & Chondroitin at reducing joint discomfort. It contains phospholipid based Omega 3s, Zanthin® Natural Astaxanthin and Flexuron® (unique proprietary HA). He will explain how it provides joint discomfort relief and improves joint function by reducing inflammation & oxidative stress within joints as well as restoring connective tissue & synovial fluid.
Dr. Rudi Moerck